puromycin aminonucleoside has been researched along with endothelin-1 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ebihara, I; Koide, H; Nakamura, T; Tomino, Y | 1 |
Chang, JM; Chen, HC; Guh, JY; Hwang, SJ; Lai, YH; Tsai, JC | 1 |
Ikebe, M; Nakayama, Y; Nonoguchi, H; Shimada, K; Tanzawa, K; Tashima, Y; Tomita, K | 1 |
Akagawa, Y; Kaneko, K; Kimata, T; Kino, J; Kitao, T; Tsuji, S; Yamanouchi, S | 1 |
4 other study(ies) available for puromycin aminonucleoside and endothelin-1
Article | Year |
---|---|
Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Azepines; Enalapril; Endothelin Receptor Antagonists; Endothelin-1; Extracellular Matrix; Gelatinases; Glycoproteins; Indoles; Kidney Glomerulus; Male; Matrix Metalloproteinase 2; Metalloendopeptidases; Nephrosis; Protease Inhibitors; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; RNA, Messenger; Tissue Inhibitor of Metalloproteinases | 1997 |
Plasma and urinary endothelin-1 in focal segmental glomerulosclerosis.
Topics: Adult; Animals; Disease Models, Animal; Endothelin-1; Female; Glomerulosclerosis, Focal Segmental; Humans; Injections, Subcutaneous; Male; Puromycin Aminonucleoside; Rats; Rats, Wistar | 2001 |
Regulation of endothelin-converting enzyme 1 in nephrotic syndrome in rats.
Topics: Animals; Aspartic Acid Endopeptidases; Atrial Natriuretic Factor; Bosentan; Cyclic GMP; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Endothelin-Converting Enzymes; Enzyme Induction; Gene Expression Regulation, Enzymologic; Kidney Glomerulus; Male; Metalloendopeptidases; Nephrons; Nephrotic Syndrome; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfonamides; Time Factors | 2003 |
Antiproteinuric effect of an endothelin-1 receptor antagonist in puromycin aminonucleoside-induced nephrosis in rat.
Topics: Animals; B7-1 Antigen; Blood Pressure; Body Weight; Creatinine; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin-1; Female; Kidney; Kidney Diseases; Kidney Glomerulus; Nephrosis; Nephrotic Syndrome; NF-kappa B; Phenylpropionates; Podocytes; Proteinuria; Puromycin Aminonucleoside; Pyridazines; Rats; Rats, Wistar; Receptor, Endothelin A; Toll-Like Receptor 3 | 2018 |